TY - JOUR
KW - Child
KW - Child of Impaired Parents
KW - Female
KW - Humans
KW - Infant, Newborn
KW - Neonatal Abstinence Syndrome/prevention & control
KW - Obstetrics
KW - Opioid-Related Disorders/prevention & control
KW - Pregnancy
KW - Pregnancy Complications/prevention & control
KW - Pregnancy Outcome
KW - United States
AU - U. M. Reddy
AU - J. M. Davis
AU - Z. Ren
AU - M. F. Greene
AU - Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes Workshop Invited Speakers
A1 - 
AB - In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human Development invited experts to a workshop to address numerous knowledge gaps and to review the evidence for the screening and management of opioid use in pregnancy and neonatal abstinence syndrome. The rising prevalence of opioid use in pregnancy has led to a concomitant dramatic fivefold increase in neonatal abstinence syndrome over the past decade. Experts from diverse disciplines addressed research gaps in the following areas: 1) optimal screening for opioid use in pregnancy; 2) complications of pregnancy associated with opioid use; 3) appropriate treatments for pregnant women with opioid use disorders; 4) the best approaches for detecting, treating, and managing newborns with neonatal abstinence syndrome; and 5) the long-term effects of prenatal opioid exposure on children. Workshop participants identified key scientific opportunities to advance the understanding of opioid use disorders in pregnancy and to improve outcomes for affected women, their children, and their families. This article provides a summary of the workshop presentations and discussions.
AD - Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, the Tufts University School of Medicine, Boston, Massachusetts, and the Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
BT - Obstetrics and gynecology
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1097/AOG.0000000000002054
IS - 1
JF - Obstetrics and gynecology
M1 - Journal Article
N2 - In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human Development invited experts to a workshop to address numerous knowledge gaps and to review the evidence for the screening and management of opioid use in pregnancy and neonatal abstinence syndrome. The rising prevalence of opioid use in pregnancy has led to a concomitant dramatic fivefold increase in neonatal abstinence syndrome over the past decade. Experts from diverse disciplines addressed research gaps in the following areas: 1) optimal screening for opioid use in pregnancy; 2) complications of pregnancy associated with opioid use; 3) appropriate treatments for pregnant women with opioid use disorders; 4) the best approaches for detecting, treating, and managing newborns with neonatal abstinence syndrome; and 5) the long-term effects of prenatal opioid exposure on children. Workshop participants identified key scientific opportunities to advance the understanding of opioid use disorders in pregnancy and to improve outcomes for affected women, their children, and their families. This article provides a summary of the workshop presentations and discussions.
PP - United States
PY - 2017
SN - 1873-233X; 0029-7844
SP - 10
EP - 28
EP - 
T1 - Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver NICHHD, ACOG, AAP, SMFM, CDC, and the March of Dimes Foundation
T2 - Obstetrics and gynecology
TI - Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver NICHHD, ACOG, AAP, SMFM, CDC, and the March of Dimes Foundation
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 28594753
U3 - 10.1097/AOG.0000000000002054
VL - 130
VO - 1873-233X; 0029-7844
Y1 - 2017
Y2 - Jul
ER -